KANUMA Trademark

Trademark Overview

On Wednesday, November 26, 2014, a trademark application was filed for KANUMA with the United States Patent and Trademark Office. The USPTO has given the KANUMA trademark a serial number of 86465336. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, December 10, 2025. This trademark is owned by Synageva BioPharma Corp.. The KANUMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for rare, terminal, liver and genetic diseases and dyslipidemia
kanuma

General Information

Serial Number86465336
Word MarkKANUMA
Filing DateWednesday, November 26, 2014
Status800 - REGISTERED AND RENEWED
Status DateWednesday, December 10, 2025
Registration Number4942307
Registration DateTuesday, April 19, 2016
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 28, 2015

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the word "KANUMA" followed by four left-facing, two-dimensional arcs of staggered lengths capped with dots; the first and last arcs have one dot, the second arc has three dots and the third arc has two dots; the color gray is intended to show shading or contrast only.
Goods and ServicesPharmaceutical preparations for rare, terminal, liver and genetic diseases and dyslipidemia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 4, 2014
Primary Code005
First Use Anywhere DateThursday, January 7, 2016
First Use In Commerce DateThursday, January 7, 2016

Trademark Owner History

Party NameALEXION PHARMACEUTICALS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameALEXION PHARMACEUTICALS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressNEW HAVEN, CT 065104125
Party NameSynageva BioPharma Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameSynageva BioPharma Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Saturday, November 29, 2014NEW APPLICATION ENTERED
Thursday, December 4, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 5, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, February 26, 2015ASSIGNED TO EXAMINER
Friday, February 27, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 20, 2015ASSIGNED TO LIE
Tuesday, March 24, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 8, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 28, 2015PUBLISHED FOR OPPOSITION
Tuesday, April 28, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 23, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 25, 2015SOU TEAS EXTENSION RECEIVED
Wednesday, November 25, 2015SOU EXTENSION 1 FILED
Wednesday, November 25, 2015SOU EXTENSION 1 GRANTED
Friday, November 27, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 4, 2016TEAS STATEMENT OF USE RECEIVED
Wednesday, March 2, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, March 10, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 4, 2016USE AMENDMENT FILED
Monday, March 14, 2016STATEMENT OF USE PROCESSING COMPLETE
Thursday, March 17, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 18, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 19, 2016REGISTERED-PRINCIPAL REGISTER
Friday, November 9, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, November 9, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 19, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, April 5, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, October 3, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, October 3, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, October 3, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, April 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 18, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 18, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 18, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 18, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Saturday, April 19, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, August 28, 2025TEAS SECTION 8 & 9 RECEIVED
Wednesday, December 10, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, December 10, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, December 10, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, December 10, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

kanuma genetic diseases dyslipidemia liver terminal preparations rare pharmaceutical